Genetic Technologies Ltd has released a press release.
GeneType Published in PLUS ONE for CVD & Type 2 Diabetes
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- AGM Presentation and Chairmans Address
- Genetype for Ovarian Cancer published in European Journal
- GeneType Outperforms Traditional Risk Assessments
- GTG Building Momentum on Commercial Plans
- Annual Report to Shareholders and Appendix 4E
Later from Genetic Technologies
- Colorectal Cancer Model Presented at ASCOGI Cancer Symposium
- Appendix 4C and Quarterly Business Update December 2022
- GTG to form Strategic Alliance with global leader QIAGEN
- World First Comprehensive Risk Test-Breast & Ovarian Cancer
- Genetic Technologies Announces US$5M Registered Direct Offer
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies